Laguna Hills-based startup Glaukos Corp. said today that it has closed on a $30 million round of venture capital funding.
Glaukos’ iStent is implanted in the eye to treat glaucoma. IStent received Food and Drug Administration approval last June.
Palo Alto-based Meritech Capital Partners, a returning investor, led Glaukos’ latest funding. Other participants include Versant Venture Management LLC, which has an office in Newport Beach, and Domain Associates, which was once located in Laguna Hills and is now based in San Diego.
The company’s management includes several veterans of the county’s medical device and drug industry who have worked at Irvine-based Allergan Inc. and Edwards Lifesciences Corp., as well as at Santa Ana-based Abbott Medical Optics, previously Advanced Medical Optics Inc.
